Table 1.
Characteristic | No. of Patients |
---|---|
Gender | |
Male | 23 |
Female | 18 |
Age (years) | |
Median | 68.0 |
Average | 65.6 |
Range | 35–79 |
Primary23 | |
Acending | 23 |
Transverse | 5 |
Descending | 1 |
Sigmoid | 4 |
Rectosigmoid | 7 |
PS | |
0 | 33 |
1 | 8 |
Stage | |
II | 14 |
IIIA | 15 |
IIIB | 12 |
Pathological tumor stage | |
T1 | 4 |
T2 | 31 |
T3 | 6 |
T4 | 0 |
Pathological nodal stage | |
N0 | 14 |
N1 | 19 |
N2 | 8 |
Lymphatic invasion | |
Ly0 | 7 |
Ly1 | 26 |
ly2 | 7 |
ly3 | 1 |
Venous invasion | |
v0 | 14 |
v1 | 15 |
v2 | 12 |
v3 | 0 |
Pathology | |
Tub1 | 18 |
Tub2 | 16 |
Por1 | 6 |
Muc | 1 |
CEA level (0-5.0 ng/ml) | |
Below normal range | 17 |
Over normal range | 23 |
C19-9A level (0-37.0 ng/ml) | |
Below normal range | 32 |
Over normal range | 9 |